US Patent Issued to SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT on March 18 for "Hydrazone amide derivatives and use thereof in preparation of anti-osteoporosis drugs" (Chinese Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,459, issued on March 18, was assigned to SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT Co. LTD. (Guangdong, China).

"Hydrazone amide derivatives and use thereof in preparation of anti-osteoporosis drugs" was invented by Dane Huang (Guangdong, China), Chao Zhao (Guangdong, China), Qiong Gu (Guangdong, China) and Jun Xu (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a new class of hydrazone amide derivatives and the use thereof in the preparation of anti-osteoporosis drugs, wherein the structural formula of the hydrazone amide derivative is as shown in formula (I), and same are a new class of compounds with an anti-o...